We developed and validated the first serum enzyme-linked immunosorbent assay for
hepcidin, the principal iron-regulatory hormone that has been very difficult to measure. In …

Hepcidin—A Potential Novel Biomarker for Iron Status in Chro... : Clinical Journal of the
American Society of Nephrology Hepcidin—A Potential Novel Biomarker for Iron Status in …

The recently discovered iron regulatory peptide hormone hepcidin holds promise as a novel
biomarker in iron metabolism disorders. To date, various mass spectrometry and …

Context: The mechanisms by which testosterone increases hemoglobin and hematocrit are
unknown. Objective: The aim was to test the hypothesis that testosterone-induced increase …

Background Anemia associated with chronic kidney disease (CKD) often requires treatment
with recombinant human erythropoietin (EPO). Hypoxia-inducible factor− prolyl hydroxylase …

Background: Hepcidin is a key regulator of iron homeostasis, but to date no studies have
examined the effect of hepcidin on iron absorption in humans. Objective: Our objective was …

BACKGROUND Absolute plasma hepcidin concentrations measured by various procedures
differ substantially, complicating interpretation of results and rendering reference intervals …

BACKGROUND/AIMS: The dysmetabolic iron overload syndrome (DIOS) is a common
disorder but its origin remains unclear. METHODS: A case-control study was conducted to …

Background Hepcidin concentrations measured by various methods differ considerably,
complicating interpretation. Here, a previously identified plasma-based candidate secondary …

Background; Hepcidin regulates iron homeostasis by blocking iron absorption from the gut
and iron release from macrophage and hepatocyte stores. Hepcidin levels are elevated in …